Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation, Stock Options, Restricted Stock Units and Warrants (Tables)

v3.23.2
Stock-Based Compensation, Stock Options, Restricted Stock Units and Warrants (Tables)
6 Months Ended
Jun. 30, 2023
Stock-Based Compensation, Restricted Stock and Stock Options [Abstract]  
Schedule of Statements of Operations The Company recognized total expenses for stock-based compensation during the six months ended June 30, 2023 and 2022, which are included in the accompanying statements of operations, as follows (in thousands):
    Three months ended
June 30,
    Six months ended
June 30,
 
    2023     2022     2023     2022  
                         
Research and development expenses   $ 45     $ 445     $ 104     $ 500  
Selling, general and administrative expenses     87       1,003       209       2,031  
Total stock-based compensation   $ 132     $ 1,448     $ 313     $ 2,531  
Schedule of Activity Under the 2016 and 2020 Plans A summary of activity under the 2016 and 2020 Plans for the six months ended June 30, 2023 is as follows:
    Shares
Underlying
Options
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
(Years)
    Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2021  
 
   
 
   
 
   
 
 
Granted  
 
   
 
   
 
   
 
 
Canceled  
 
   
 
   
 
   
 
 
Forfeited  
 
   
 
   
 
   
 
 
Outstanding at December 31, 2022     159,295     $ 153.35       6.5     $ 26,188  
Forfeited     (1,516 )   $ 196.86      
-
         
Outstanding at June 30, 2023     157,779     $ 157.47       6.0     $
-
 
                                 
Exercisable at June 30, 2023     142,884     $ 167.85       5.7     $
-
 

 

Schedule of Restricted Stock Activity A summary of the Company’s restricted stock activity during the six months ended June 30, 2023 is as follows:
    Number of
Shares
    Weighted
Average
Grant-Date
Fair Value
 
Unvested at December 21, 2022     10,483     $ 82.02  
Vested     (3,344 )   $ 104.04  
Unvested at June 30, 2023     7,139     $ 71.68  
Schedule of Warrant (Excluding Penny Warrants) Activity A summary of the Company’s warrant (excluding penny warrants) activity during the six months ended June 30, 2023 is as follows:
    Shares
Underlying
Warrants
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
(Years)
    Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2022     461,066     $ 44.88       4.5     $
    -
 
Issued     1,405,797     $ 11.42       4.7      
 
 
Exercised     (106,768 )   $ 19.20      
-
     
 
 
Outstanding at June 30, 2023     1,760,095     $ 18.96       4.7     $
-